References
- WHO. Global atlas of palliative care at the end of Life. Geneva: WHO; 2014.
- Ni Chroinin D, Goldsbury DE, Beveridge A, Davidson PM, Girgis A, Ingham N, et al. Health-services utilisation amongst older persons during the last year of life: a population-based study. BMC Geriatr 2018;18(1):317. doi: 10.1186/s12877-018-1006-x
- Wheatley VJ, Baker JI. “Please, I want to go home”: ethical issues raised when considering choice of place of care in palliative care. Postgrad Med J 2007;83(984):643–8. doi: 10.1136/pgmj.2007.058487
- Australian Commission on Safety and Quality in Health Care. National consensus statement: essential elements for safe and high-quality end-of-life care. Sydney: ACSQHC; 2015.
- Lucey M, McQuillan R, MacCallion A, Corrigan M, Flynn J, Connaire K. Access to medications in the community by patients in a palliative setting. A systems analysis. Palliat Med 2008;22(2):185–9. doi: 10.1177/0269216307085722
- Wowchuk SM, Wilson EA, Embleton L, Garcia M, Harlos M, Chochinov HM. The palliative medication kit: an effective way of extending care in the home for patients nearing death. J Palliat Med 2009;12(9):797–803. doi: 10.1089/jpm.2009.0048
- O’Connor M, Fisher C, French L, Halkett G, Jiwa M, Hughes J. Exploring the community pharmacist’s role in palliative care: focusing on the person not just the prescription. Patient Educ Couns 2011;83(3):458–64. doi: 10.1016/j.pec.2011.04.037
- Miller EJ, Morgan JD, Blenkinsopp A. How timely is access to palliative care medicines in the community? A mixed methods study in a UK city. BMJ Open 2019;9(11):e029016. doi: 10.1136/bmjopen-2019-029016
- Swerissen H, Duckett S. Dying well. Grattan Institute; 2014.
- Glare P, Dickman A, Goodman M. Symptom control in care of the dying. In: Ellershaw J, Wilkinson S, (eds.) Care of the dying. New York: Oxford; 2011. p. 33–61.
- Tait PA, Gray J, Hakendorf P, Morris B, Currow DC, Rowett DS. Community pharmacists: a forgotten resource for palliative care. BMJ Support Palliat Care 2013;3(4):436–43. doi: 10.1136/bmjspcare-2012-000440
- Tait P, Morris B, To T. Core palliative medicines: meeting the needs of noncomplex community patients. Aust Fam Physician 2014;43(1):29–32.
- Tait P, Horwood C, Hakendorf P, To T. Improving community access to terminal phase medicines through the implementation of a ‘core medicines list’ in South Australian community pharmacies. BMJ Support Palliat Care 2020;10(1):e4. doi: 10.1136/bmjspcare-2016-001191
- Clinical Excellence Commission. NSW community palliative care initiative phase 1 report June 2018. Sydney: Clinical Excellence Commission; 2018.
- Hugo Centre for Migration and Population Research. Pharmacy ARIA (PHARIA). 2019 [cited 2020 Mar 12]. Available from: https://www.adelaide.edu.au/hugo-centre/services/pharia#further-information.
- Hussainy SY, Box M, Scholes S. Piloting the role of a pharmacist in a community palliative care multidisciplinary team: an Australian experience. BMC Palliat Care 2011;10:16. doi: 10.1186/1472-684X-10-16
- Dyer SM, Liu E, Gnanamanickam ES, Milte R, Easton T, Harrison SL, et al. Clustered domestic residential aged care in Australia: fewer hospitalisations and better quality of life. Med J Aust 2018;208(10):433–8. doi: 10.5694/mja17.00861
- PalliAGED. Palliative care symptom management medicines for Australians living in the community. 2019 [cited 2020 Mar 12]. Available from: https://www.palliaged.com.au/Portals/5/Documents/medicine-List-update.pdf.
- Australian Government Department of Health (2019) Pharmaceutical benefits scheme. 2019 [cited 2020 Mar 12]. Available from: http://www.pbs.gov.au/pbs/home.
- Lindqvist O, Lundquist G, Dickman A, Bukki J, Lunder U, Hagelin CL, et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med 2013;16(1):38–43. doi: 10.1089/jpm.2012.0205